A randomized, double-blind phase I/IIa study of intranasal glutathione in Parkinson's disease (Q36172557)

12 August 2017

A randomized, double-blind phase I/IIa study of intranasal glutathione in Parkinson's disease (English)

1 reference

12 August 2017

1 reference

James B Leverenz

2

0 references

author name string

Laurie K Mischley

1

1 reference

12 August 2017

Richard C Lau

3

1 reference

12 August 2017

Nayak L Polissar

4

1 reference

12 August 2017

Moni B Neradilek

5

1 reference

12 August 2017

Ali Samii

6

1 reference

12 August 2017

Leanna J Standish

7

1 reference

12 August 2017

language of work or name

English

0 references

publication date

31 July 2015

1 reference

12 August 2017

1 reference

12 August 2017

30

1 reference

12 August 2017

12

1 reference

12 August 2017

1696-1701

1 reference

Glutathione: new roles in redox signaling for an old antioxidant

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609266

Redox modification of proteins as essential mediators of CNS autophagy and mitophagy.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609266

Safety survey of intranasal glutathione.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609266

Recent advances in the treatment of neurodegenerative diseases based on GSH delivery systems

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609266

Incidental Lewy body disease and preclinical Parkinson disease

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609266

Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609266

Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609266

Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609266

The systemic availability of oral glutathione

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609266

Reduced intravenous glutathione in the treatment of early Parkinson's disease

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609266

Glutathione: new candidate neuropeptide in the central nervous system

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609266

Nullity of GSTT1/GSTM1 related to pesticides is associated with Parkinson's disease.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609266

The current and projected economic burden of Parkinson's disease in the United States

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609266

Determination of minimal clinically important change in early and advanced Parkinson's disease

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609266

Depletion of GSH in glial cells induces neurotoxicity: relevance to aging and degenerative neurological diseases

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609266

Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson's disease

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609266

A clinical study of N-acetylcysteine treatment in chronic hepatitis B patients

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4609266

Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death

23 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26230671

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Psychometric and clinimetric validity of the 20-Item Sino-Nasal Outcome Test (SNOT-20).

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26230671

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Treatment of advanced malignancies with high-dose acetaminophen and N-acetylcysteine rescue

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26230671

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/MDS.26351

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

26230671

1 reference